11/25/2025
New Blog Post - ๐ ๐ฒ๐ฒ๐ ๐๐ต๐ฒ ๐๐๐๐ต๐ผ๐ฟ
This month, Dr. ๐๐ฒ๐ป ๐๐ฟ๐ฎ๐ถ๐ป๐ฎ๐ฟ๐ฑ takes us behind the scenes of the highly anticipated ๐ฆ๐จ๐ฃ๐๐ฅ๐๐๐ง ๐๐๐๐ฑ๐ โ a prospective, double-masked, multicenter trial comparing clopidogrel vs. rivaroxaban for preventing recurrence of cardiogenic arterial thromboembolism (ATE) in cats.
What did the trial reveal?
- ๐๐ผ๐๐ต ๐ฑ๐ฟ๐๐ด๐ ๐ฝ๐ฒ๐ฟ๐ณ๐ผ๐ฟ๐บ๐ฒ๐ฑ ๐ฒ๐พ๐๐ฎ๐น๐น๐ well in prolonging time to ATE recurrence.
- Many cats lived far longer than expected โ reinforcing that ๐๐ง๐ ๐ถ๐ ๐๐๐ฟ๐๐ถ๐๐ฎ๐ฏ๐น๐ฒ ๐๐ถ๐๐ต ๐ฎ๐ฝ๐ฝ๐ฟ๐ผ๐ฝ๐ฟ๐ถ๐ฎ๐๐ฒ ๐๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐.
Dr. Brainard also reflects on the studyโs outcomes, future directions, and the feasibility of complementary investigations that could build on these findings.
Read the full Blog Post on VetUpdates.org